Final analysis of a trial of M72/AS01E vaccine to prevent Tuberculosis
The final analysis of a multi-site medical trial involving the University of Cape Town (UCT) has produced the first signal of a potentially effective vaccine against tuberculosis (TB) in almost 100 years.
News from the South African Tuberculosis Vaccine Initiative.
Immunopathology of TB: Studying the role of the lymph nodes in the TB spectrum.
Researchers working on a novel study of the lymph nodes of humans discuss this complex project which is studying lymph node immunology, and the role of these organs in the progression to TB disease with a Wellcome Leap grant.
Read more
World TB Day
World TB Day is observed annually on March 24, amplifies the need to strengthen our fight against TB, the deadliest infectious disease. TB continues to affect millions globally, inflicting severe health, social, and economic consequences.
Read more
Research Focus: Titan Vaccine Research Project
Dr Munyaradzi Musvosvi speaks about the Titan Vaccine Research Project which will allow the selection of the most promising TB vaccine candidates.
Read more
Shining a spotlight on science
SATVI's Professor Nemes and Doctor Young-Bailie recently participated in Soapbox Science co-hosted by the University of Cape Town (UCT), iThemba LABS, the South African Astronomical Observatory (SAAO), and the V&Alfred Waterfront.
Read more
Vacancies
No vacancies found
Previous highlights
Video: World TB Day: Vaccine trial inspires SATVI clinicians to imagine a world without TB
On World TB Day, the University of Cape Town (UCT) shines the spotlight on phase three of a clinical trial led by clinicians at the South African Tuberculosis Vaccine Initiative (SATVI).
Download: SATVI 20 year history
The corporate history of the South African Tuberculosis Vaccine Initiative is available online. This history is the result of more than 20 interviews conducted over a period of about one year with SATVI staff and students, including ma
Download: SATVI 2022 Annual Report
The SATVI Annual Report 2022 is available for download.
SATVI researchers amongst the top UCT researchers studying BCG: 1989 - 2021
The University of Cape Town is leading international research into the only licensed TB vaccine, Bacille Calmette-Guerin (BCG), according to a new study.
Upcoming Events
No upcoming events.